Skip to main content
. Author manuscript; available in PMC: 2020 Oct 1.
Published in final edited form as: J Thorac Oncol. 2019 Jul 11;14(10):1853–1859. doi: 10.1016/j.jtho.2019.06.027

Table 3:

Adverse Events Attributed to Treatment

Adverse event Grade of AE N = 32

3 4 5
AST increased 1(3%)
Anemia 4(13%)
Anorexia 1(3%)
Chronic Kidney Disease 1(3%)
Dyspnea 1(3%)
Fatigue 5(16%)
Generalized muscle weakness 1(3%)
Hyperglycemia 2(6%)
Hyponatremia 1(3%)
Hypotension 1(3%)
Lung infection 1(3%)
Lymphopenia 6(19%) 3(9%)
Neoplasms, all 1(3%)
Neutropenia 5(16%)
Thrombocytopenia 1(3%) 1(3 %)
Leucopenia 6(19%)
Maximum grade of any AE 13(41%) 5(16%) 0